Global Thrombosis Test: Occlusion Is Attributable to Shear-Induced Platelet Thrombus Formation

We read the paper by Clavería and co-workers with interest.[1] We strongly believe that the conclusions of their paper, suggesting that occlusion (occlusion time (OT)) in the global thrombosis test (GTT) is due to coagulation, rather than shear-induced platelet thrombus formation, is wrong and the evidence and arguments they present are fundamentally flawed.

The authors have made major errors both in the approach to their experiments and in their interpretations of their results. The evidence which they demonstrate, shows that occlusion in the GTT is, in fact, caused by high shear-induced platelet thrombus formation, the complete opposite to their interpretation of their results. We set out below the evidence for that.

Publikationsverlauf

Eingereicht: 11. Oktober 2021

Angenommen: 16. November 2021

Accepted Manuscript online:
23. November 2021

Artikel online veröffentlicht:
15. Februar 2022

• References

• 1 Clavería V, Yang PJ, Griffin MT, Ku DN. Global thrombosis test: occlusion by coagulation or SIPA?. TH Open 2021; 5 (03) e400-e410
• 2 Yamamoto J, Yamashita T, Ikarugi H. et al. Görög thrombosis test: a global in-vitro test of platelet function and thrombolysis. Blood Coagul Fibrinolysis 2003; 14 (01) 31-39
• 3 Farag M, Spinthakis N, Gue YX. et al. Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study. Eur Heart J 2019; 40 (03) 295-305
• 4 Saba HI, Saba SR, Morelli GA. Effect of heparin on platelet aggregation. Am J Hematol 1984; 17 (03) 295-306
• 5 Saba HI, Saba SR, Blackburn CA, Hartmann RC, Mason RG. Heparin neutralization of PGI2: effects upon platelets. Science 1979; 205 (4405): 499-501
• 6 John LCH, Rees GM, Kovacs IB. Effect of heparin on in vitro platelet reactivity in cardiac surgical patients–a comparative assessment by whole blood platelet aggregometry and haemostatometry. Thromb Res 1992; 66 (06) 649-656
• 7 Arantes FBB, Menezes FR, Franci A. et al. Influence of direct thrombin inhibitor and low molecular weight heparin on platelet function in patients with coronary artery disease: a prospective interventional trial. Adv Ther 2020; 37 (01) 420-430
• 8 Slaughter TF, Sreeram G, Sharma AD, El-Moalem H, East CJ, Greenberg CS. Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagul Fibrinolysis 2001; 12 (02) 85-93
• 9 Williams MS, Ng'alla LS. Heparin therapy leads to platelet activation and prolongation of PFA-100 closure time. J Cardiovasc Pharmacol Ther 2005; 10 (04) 273-280
• 10 Griffin MJ, Rinder HM, Smith BR. et al. The effects of heparin, protamine, and heparin/protamine reversal on platelet function under conditions of arterial shear stress. Anesth Analg 2001; 93 (01) 20-27
• 11 Gorog DA, Fuster V. Platelet function tests in clinical cardiology: unfulfilled expectations. J Am Coll Cardiol 2013; 61 (21) 2115-2129
• 12 Gorog DA, Fayad ZA, Fuster V. Arterial thrombus stability: does it matter and can we detect it?. J Am Coll Cardiol 2017; 70 (16) 2036-2047
• 13 Koupenova M, Kehrel BE, Corkrey HA, Freedman JE. Thrombosis and platelets: an update. Eur Heart J 2017; 38 (11) 785-791
• 14 Alkarithi G, Duval C, Shi Y, Macrae FL, Ariëns RAS. Thrombus structural composition in cardiovascular disease. Arterioscler Thromb Vasc Biol 2021; 41 (09) 2370-2383
• 15 Silvain J, Collet J-P, Nagaswami C. et al. Composition of coronary thrombus in acute myocardial infarction. J Am Coll Cardiol 2011; 57 (12) 1359-1367
• 16 Uchida Y, Uchida Y, Sakurai T, Kanai M, Shirai S, Morita T. Characterization of coronary fibrin thrombus in patients with acute coronary syndrome using dye-staining angioscopy. Arterioscler Thromb Vasc Biol 2011; 31 (06) 1452-1460
• 17 Uchida Y, Uchida Y. Dye-staining angioscopy for coronary artery disease. Curr Cardiovasc Imaging Rep 2015; 8 (04) 10
• 18 Chernysh IN, Nagaswami C, Kosolapova S. et al. The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli. Sci Rep 2020; 10 (01) 5112
• 19 Granger CB, White HD, Bates ER, Ohman EM, Califf RM. A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction. Am J Cardiol 1994; 74 (12) 1220-1228
• 20 Baxter-Jones CS, White HD, Anderson JL. An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction. J Interv Cardiol 1993; 6 (01) 15-23
• 21 Tritschler T, Kraaijpoel N, Le Gal G, Wells PS. Venous thromboembolism: advances in diagnosis and treatment. JAMA 2018; 320 (15) 1583-1594
• 22 Nesbitt WS, Westein E, Tovar-Lopez FJ. et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 2009; 15 (06) 665-673
• 23 Spinthakis N, Farag M, Gue YX, Srinivasan M, Wellsted DM, Gorog DA. Effect of P2Y₁₂ inhibitors on thrombus stability and endogenous fibrinolysis. Thromb Res 2019; 173: 102-108
• 24 Østerud B, Brox JH. The clotting time of whole blood in plastic tubes: the influence of exercise, prostacyclin and acetylsalicylic acid. Thromb Res 1983; 29 (04) 425-435
• 25 Hathcock JJ. Flow effects on coagulation and thrombosis. Arterioscler Thromb Vasc Biol 2006; 26 (08) 1729-1737
• 26 Ratnatunga CP, Edmondson SF, Rees GM, Kovacs IB. High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation. Circulation 1992; 85 (03) 1077-1082
• 27 Görög P, Kovacs IB. Coagulation of flowing native blood: advantages over stagnant (tube) clotting tests. Thromb Res 1991; 64 (05) 611-619
• 28 Saraf S, Christopoulos C, Salha IB, Stott DJ, Gorog DA. Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction. J Am Coll Cardiol 2010; 55 (19) 2107-2115
• 29 Gorog DA, Yamamoto J, Saraf S. et al. First direct comparison of platelet reactivity and thrombolytic status between Japanese and Western volunteers: possible relationship to the “Japanese paradox.”. Int J Cardiol 2011; 152 (01) 43-48
• 30 Taomoto K, Ohnishi H, Kuga Y. et al. Platelet function and spontaneous thrombolytic activity of patients with cerebral infarction assessed by the global thrombosis test. Pathophysiol Haemost Thromb 2010; 37 (01) 43-48
• 31 Otsui K, Gorog DA, Yamamoto J. et al. Global thrombosis test—a possible monitoring system for the effects and safety of dabigatran. Thromb J 2015; 13: 39
• 32 Suehiro A, Wakabayashi I, Yamashita T, Yamamoto J. Attenuation of spontaneous thrombolytic activity measured by the global thrombosis test in male habitual smokers. J Thromb Thrombolysis 2014; 37 (04) 414-418
• 33 Rosser G, Tricoci P, Morrow D. et al. PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease. J Thromb Thrombolysis 2014; 38 (04) 423-429
• 34 Yamamoto J, Inoue N, Otsui K, Ishii H, Gorog DA. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential. Thromb Res 2014; 133 (05) 919-926
• 35 Suehiro A, Wakabayashi I, Uchida K, Yamashita T, Yamamoto J. Impaired spontaneous thrombolytic activity measured by global thrombosis test in males with metabolic syndrome. Thromb Res 2012; 129 (04) 499-501
• 36 Ikarugi H, Yamashita T, Aoki R, Ishii H, Kanki K, Yamamoto J. Impaired spontaneous thrombolytic activity in elderly and in habitual smokers, as measured by a new global thrombosis test. Blood Coagul Fibrinolysis 2003; 14 (08) 781-784
• 37 Didisheim P. Microscopically typical thrombi and hemostatic plugs in TeflonTM arteriovenous shunts. In: Johnson SA, Guest MM. eds. Dynamics of Thrombus Formation and Dissolution Lippincott. 1969
• 38 Chandler AB. In vitro thrombotic coagulation of the blood; a method for producing a thrombus. Lab Invest 1958; 7 (02) 110-114
• 39 Mutch NJ, Moore NR, Mattsson C, Jonasson H, Green AR, Booth NA. The use of the Chandler loop to examine the interaction potential of NXY-059 on the thrombolytic properties of rtPA on human thrombi in vitro. Br J Pharmacol 2008; 153 (01) 124-131
• 40 Salzman EW. Measurement of platelet adhesiveness: progress report. Thromb Diath Haemorrh Suppl 1967; 26: 303-307
• 41 Çinar Y, Şenyol AM, Duman K. Blood viscosity and blood pressure: role of temperature and hyperglycemia. Am J Hypertens 2001; 14 (5 Pt 1): 433-438
• 42 Heemskerk JWM, Mattheij NJA, Cosemans JMEM. Platelet-based coagulation: different populations, different functions. J Thromb Haemost 2013; 11 (01) 2-16
• 43 Jackson SP, Nesbitt WS, Westein E. Dynamics of platelet thrombus formation. J Thromb Haemost 2009; 7 (Suppl. 01) 17-20